The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Authors
Keywords
-
Journal
CELL CYCLE
Volume 15, Issue 11, Pages 1462-1470
Publisher
Informa UK Limited
Online
2016-04-22
DOI
10.1080/15384101.2016.1175258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas
- (2016) Vinicius de Lima Vazquez et al. MELANOMA RESEARCH
- Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
- (2016) Lorey K. Smith et al. PHARMACOLOGICAL RESEARCH
- Metabolic reprogramming supports the invasive phenotype in malignant melanoma
- (2015) Ingrid J. Bettum et al. CANCER LETTERS
- BRAF inhibitors: the current and the future
- (2015) Weijiang Zhang CURRENT OPINION IN PHARMACOLOGY
- Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
- (2015) Anna Niezgoda et al. Biomed Research International
- Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
- (2015) Arnaldur Hall et al. Oncotarget
- Expression of cancer-related carbonic anhydrases IX and XII in normal skin and skin neoplasms
- (2014) Leo Syrjänen et al. APMIS
- The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype
- (2014) Bárbara Sousa et al. BMC CANCER
- Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection ofBRAFV600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma
- (2012) Steven Anderson et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?
- (2012) Friederike Erdmann et al. INTERNATIONAL JOURNAL OF CANCER
- Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate
- (2012) Odília Queirós et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Importance of glycolysis and oxidative phosphorylation in advanced melanoma
- (2012) Jonhan Ho et al. Molecular Cancer
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- Lactate: A Metabolic Key Player in Cancer
- (2011) F. Hirschhaeuser et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker
- (2011) Kátia C. Carvalho et al. Clinics
- Comparative Metabolic Flux Profiling of Melanoma Cell Lines
- (2011) David A. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
- (2011) H.-J. Shin et al. JOURNAL OF CELL SCIENCE
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
- (2010) Céline Pinheiro et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BRAF V600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
- (2010) Monica Zerilli et al. MODERN PATHOLOGY
- Metabolic Approaches to Treatment of Melanoma
- (2009) P. Hersey et al. CLINICAL CANCER RESEARCH
- Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
- (2009) Olga Martinho et al. HISTOPATHOLOGY
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
- Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
- (2008) Céline Pinheiro et al. VIRCHOWS ARCHIV
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now